Bartlett & Co’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$83K Hold
1,824
﹤0.01% 602
2023
Q3
$75K Hold
1,824
﹤0.01% 582
2023
Q2
$81K Hold
1,824
﹤0.01% 573
2023
Q1
$78K Hold
1,824
﹤0.01% 499
2022
Q4
$86K Hold
1,824
﹤0.01% 494
2022
Q3
$70K Hold
1,824
﹤0.01% 512
2022
Q2
$80K Hold
1,824
﹤0.01% 498
2022
Q1
$93K Buy
+1,824
New +$87.9K ﹤0.01% 495
2021
Q4
Sell
-1,824
Closed -$87K 780
2021
Q3
$87K Hold
1,824
﹤0.01% 438
2021
Q2
$85K Hold
1,824
﹤0.01% 435
2021
Q1
$73K Hold
1,824
﹤0.01% 473
2020
Q4
$69K Hold
1,824
﹤0.01% 481
2020
Q3
$60K Hold
1,824
﹤0.01% 470
2020
Q2
$54K Hold
1,824
﹤0.01% 483
2020
Q1
$41K Buy
+1,824
New +$52.5K ﹤0.01% 499

Other funds holding RXL

Bartlett & Co's RXL Position: Q4 2023 in Review

Bartlett & Co held its ProShares Ultra Health Care (RXL) position steady in Q4 2023 at 1,824 shares worth $83K. The position accounts for ﹤0.01% of the portfolio, ranked #602.

Bartlett & Co first reported a position in RXL in Q1 2020 and has held it in 15 quarters since. The position peaked at $93K in Q1 2022. 20 funds tracked by Wall St. Rank hold RXL as of Q4 2023.

  • Bartlett & Co held 1,824 shares of ProShares Ultra Health Care worth $83K as of Q4 2023.
  • Bartlett & Co left its ProShares Ultra Health Care share count unchanged in Q4 2023.
  • ProShares Ultra Health Care made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #602 holding.
  • Bartlett & Co first reported a position in ProShares Ultra Health Care in Q1 2020 and has held it in 15 quarters since.
  • Bartlett & Co's ProShares Ultra Health Care position peaked at $93K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.